Researcher Doda Rudnicki, who has worked with Advocacy support for 5 years at Johns Hopkins University in Baltimore Maryland, USA, writes to say that she has made the decision to leave academia and join the National Center for Advancing Translational Sciences at National Institutes of Health. "I am still adjunct faculty at Hopkins and I still have work to finish and papers to publish," she writes. "However, I have moved my family to the Potomac and my job now is to advance development of therapies by developing programs that would enhance collaboration between government, academia and industry.

She notes that she hopes her new position will allow her to impact science at a greater scale than through the research in her own laboratory. She has chosen NCATS because of its focus on rare diseases. Find out more at https://ncats.nih.gov/about and https://rarediseases.info.nih.gov/

Doda is still pursuing the confirmation and extension of her data to report on her project entitled "The role of Junctophilin-3 (JPH3) in neurone- comparison to chore in (VPS13A)," published in NA News Issue 27. A recently published review appeared in Current Opinion in Neurology, in which she has discussed HDL2 and where she sees the therapeutic effort for rare diseases needs to go. Doda participated in the Discussion and Action Points Discussion at the ChAc meeting in Ann Arbor.